Safety and Tolerability of Sodium Thiosulfate in Patients With an ACS Undergoing CAG Via Trans-radial Approach.
Status:
Completed
Trial end date:
2018-03-23
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the safety and maximum tolerable dose (MTD) of
sodium thiosulfate in patients presenting with an acute coronary syndrome and treated with
primary percutaneous coronary intervention (PPCI) via trans-radial approach in adjunction to
standard treatment.